Paper6019331
Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis.
Baastrup PC and 1 other. Arch Gen Psychiatry, 1967. Cited by 518 papers, by iCite.
Cite this record
ConductScience Library. Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis. Papers, record 6019331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6019331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bipolar Disorder | Major topic |
| Depression | Major topic |
| Lithium | Major topic |
| Adult | |
| Aged | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Middle Aged | |
| Statistics as Topic |
Source PubMed
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 518 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947601 | Korean Medication Algorithm Project for Bipolar Disorder 2026, Sixth Revision: An Executive Summary. | Clin Psychopharmacol Neurosci | 2026 | https://conductscience.org/library/papers/42947601 | PubMed |
| 41440987 | A Critical Overview of the Validity of the Current Concept of Bipolar Disorder. | J Pers Med | 2025 | https://conductscience.org/library/papers/41440987 | PubMed |
| 40872619 | The Rise of a Legend: Lithium and the Extraordinary Story of Its Discovery. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40872619 | PubMed |
| 40283967 | An Overview of the Effects of Lithium on Alzheimer's Disease: A Historical Perspective. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40283967 | PubMed |
| 39609318 | Lithium: current state of the art and future directions. | Int J Bipolar Disord | 2024 | https://conductscience.org/library/papers/39609318 | PubMed |
| 38489135 | Effectiveness of ultra-long-term lithium treatment: relevant factors and case series. | Int J Bipolar Disord | 2024 | https://conductscience.org/library/papers/38489135 | PubMed |
| 37239213 | Mood Stabilizers of First and Second Generation. | Brain Sci | 2023 | https://conductscience.org/library/papers/37239213 | PubMed |
| 36583740 | Revisiting the concept of bipolar depression: comparison of diagnostic validators between melancholic and non-melancholic episodes. | Eur Arch Psychiatry Clin Neurosci | 2024 | https://conductscience.org/library/papers/36583740 | PubMed |
| 36159362 | Therapeutic Application of Lithium in Bipolar Disorders: A Brief Review. | Cureus | 2022 | https://conductscience.org/library/papers/36159362 | PubMed |
| 35410603 | What is the Role of Lithium in Epilepsy? | Curr Neuropharmacol | 2022 | https://conductscience.org/library/papers/35410603 | PubMed |
| 34841055 | DNAzyme-Based Lithium-Selective Imaging Reveals Higher Lithium Accumulation in Bipolar Disorder Patient-Derived Neurons. | ACS Cent Sci | 2021 | https://conductscience.org/library/papers/34841055 | PubMed |
| 34834330 | Chronopharmacology in Therapeutic Drug Monitoring-Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34834330 | PubMed |
| 33375448 | Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33375448 | PubMed |
| 31877761 | Pharmacogenomic Characterization in Bipolar Spectrum Disorders. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/31877761 | PubMed |
| 30041458 | A History of the Pharmacological Treatment of Bipolar Disorder. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30041458 | PubMed |
| 29127487 | Towards a Unified Understanding of Lithium Action in Basic Biology and its Significance for Applied Biology. | J Membr Biol | 2017 | https://conductscience.org/library/papers/29127487 | PubMed |
| 28976944 | The New News about Lithium: An Underutilized Treatment in the United States. | Neuropsychopharmacology | 2018 | https://conductscience.org/library/papers/28976944 | PubMed |
| 28247268 | Lithium in the episode and suicide prophylaxis and in augmenting strategies in patients with unipolar depression. | Int J Bipolar Disord | 2017 | https://conductscience.org/library/papers/28247268 | PubMed |
| 27815414 | The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines. | Int J Neuropsychopharmacol | 2017 | https://conductscience.org/library/papers/27815414 | PubMed |
| 27226264 | Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort. | Bipolar Disord | 2016 | https://conductscience.org/library/papers/27226264 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6019331
GET https://conductscience.org/api/papers/v1/6019331/cited_by?page=2